MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Omnichannel

The Quest for Omnichannel: Is Medical Affairs Ready?

Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
man-accessing-data

New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health

Making research and data reproducible is vital to improving public health and reinstating trust in...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
EU MDR,Compliance,Rules,MedTech,Law,Regulation,Policy,Documents,Medical Device

Ensuring Alignment Across EU MDR Deliverables

How to avoid all these pitfalls and keep thriving in the EU Medical Devices market?...
finding the easiest way through a maze

Plain Language in Plain Sight: Why Making It Easier for Patients to Access Content They Understand Pays Off

With so many different types of Plain Language Summaries, and the interchangeable terms used for...

Learn more ABOUT our company.